Condensed Balance Sheets - USD ($)	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 20,800,384	$ 12,710,762
Collaboration receivable		5,000,000
Prepaid expenses	1,525,016	1,094,229
Other current assets	1,028,427	9,283,625
Total current assets	23,353,827	28,088,616
Property and equipment, net	122,436	114,112
Other assets:
Goodwill	7,647,267	7,647,267
Other non-current assets	345,961	406,956
Total assets	31,469,491	36,256,951
Current liabilities:
Accounts payable	2,019,653	1,405,734
Accrued expenses	6,135,326	2,428,193
Deferred collaboration funding, current	17,152,362	15,825,938
Other current liabilities	971,372	9,450,085
Bridge loan payable, current, at fair value	1,300,000
Total current liabilities	27,578,713	29,109,950
Deferred collaboration funding, non-current	1,963,139	8,661,109
Bridge loan payable non-current, at fair value	4,872,969
Convertible note payable, at fair value	6,962,400
Other non-current liabilities	193,751	209,497
Total liabilities	41,570,972	37,980,556
Commitments and Contingencies (Note 8)
Stockholders’ deficit:
Preferred stock, $0.0001 par value; authorized 10,000,000 shares; none issued and outstanding
Common stock, $0.0001 par value; authorized 150,000,000 shares; 14,310,244 shares issued and outstanding at March 31, 2022 and December 31, 2021	1,431	1,431
Additional paid-in capital	113,586,046	112,784,918
Accumulated deficit	(123,688,958)	(114,509,954)
Total stockholders’ deficit	(10,101,481)	(1,723,605)
Total liabilities and stockholders’ deficit	$ 31,469,491	$ 36,256,951